NCT06818890

Brief Summary

The goal of the study is to determine whether using a two-piece definitive abutment, as opposed to a traditional two-stage healing abutment connection, will reduce the loss of crestal bone surrounding the implant and improve soft tissue adaption. With the use of a manual periodontal probe, it will be recorded at four locations per implant. In order to prevent its removal during healing, an abutment base of the definitive restorative abutment will be positioned during implant surgery. Therefore, there is no departure from the standard course of treatment. An implant and crown will be used to replace a lost tooth, which will benefit the patients. Benefit to society: more predictable and enhanced functional and aesthetic treatment outcomes. Benefit to Scientific Advancement: This concept will be beneficial in maintaining the peri-implant soft tissue and bone levels. Changes in interproximal bone levels will be measured in standardized periapical digital radiographs (x-rays) once a month, which is usually not associated with any complications. The number of visits to the hospital: On the day of implant placement, 12th-week Impression Visit, 16th-week Prosthesis Placement, 20th-week 1st Month post prosthesis, follow up, 28th-week 3rd-month post prosthesis follow-up, 40th-week 6th-month post prosthesis follow-up, 64th-week 1-year follow-up after placing the definitive restoration. On every visit, radiographs will be taken. Patients should maintain regular oral hygiene to prevent future bone loss. No one else shall be privy to participants' details. Implant treatment for the participant is free. The participant will give consent for any advisable and necessary dental procedures, medications, or anaesthetics to be administered by the attending dentist or his supervised staff for diagnostic purposes or for implant placement. Also give consent to make radiographic and photographic records; these records may also include study models, x-rays, and blood studies. If implants fail, then they will be retreated free of charge. Participants understood and acknowledged that they agreed to be part of this clinical study, will keep up with the follow-up appointments, and if they want, they can choose to drop out of the study anytime on the course of study. That there is no force or influence to participate, that he/she can take enough time to decide whether to participate, and that he/she can ask any doubts to the PI at any point in time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 13, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2020

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2022

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

February 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 11, 2025

Completed
Last Updated

February 11, 2025

Status Verified

February 1, 2025

Enrollment Period

1.8 years

First QC Date

February 3, 2025

Last Update Submit

February 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Crestal Bone levels

    The crestal bone level changes at the mesial and distal interproximal areas were captured at baseline (implant placement), 1-, 3-, 6 months, and 1-year post-restoration. Intra-oral periapical digital radiographs using the digital radiograph sensor (Gendex Dental Systems, Kavo, USA) and measured in millimeters using the measuring tool in the bundled software VixWin. The process was standardized by a positioning/paralleling device (Gendex, Kavo, Germany). The radiographs were verified for any distortion by measuring the distance between the head of the implant and the apex and using the known length of the implant. The mesial and distal crestal bone levels were calculated by determining the distance from the implant head to the first visible bone contact in millimeters.

    I year follow up

Secondary Outcomes (1)

  • Peri-Implant Tissue Health

    I year follow up

Study Arms (2)

Definite abutment base

EXPERIMENTAL

The On1 base (height 1.75 mm) and the On1 healing cap and On1 abutment (Nobel Biocare AB). it is a two-piece abutment of which the base is connected to the implant on the day of implant placement.

Device: Definitive abutment base

Conventional healing abutment

ACTIVE COMPARATOR

Universal healing abutment and the universal base abutment

Device: Conventional Healing Abutment

Interventions

Definite abutment base, this is a two-piece definitive abutment where the base is connected to the implant as soon as it is placed.This abutment will allow the tissues around the implant to heal undisturbed, thus, establishing a good and healthy periimplant soft and hard tissue with long-term stability.

Definite abutment base

A healing abutment of different diameters (4.3, 5, 6 mm) and heights (1.5, 3 mm) is placed on the day of the surgery, and the flaps are sutured around them to allow for tissue healing around the abutment to create an optimum emergence profile and tissue cuff around the implant and definitive abutment.

Conventional healing abutment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adequate width and height of bone for the placement of appropriate size implant(s).
  • Well-healed edentulous sites with a minimum of 2 mm of soft tissue thickness.
  • Patients willing to participate by giving informed consent.
  • Patients agreeing to attend the planned follow-up visits.

You may not qualify if:

  • Medically compromised patients where surgery was contraindicated.
  • Patients with poor oral hygiene and/or suffering from periodontal disease.
  • Patients with insufficient quantity/quality of bone.
  • Patient with edentulous sites with a lack of attached gingiva.
  • Patients with edentulous sites with insufficient prosthetic space.
  • Patients with a history of parafunctional occlusal habits.
  • Tobacco or alcohol use or drug dependency.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yenepoya Dental College Hospital

Mangaluru, Karnataka, 575018, India

Location

Study Officials

  • Hasan Sarfaraz, MDS

    Yenepoya Dental College

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 3, 2025

First Posted

February 11, 2025

Study Start

March 13, 2019

Primary Completion

December 12, 2020

Study Completion

April 14, 2022

Last Updated

February 11, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

As a requirement for ethical clearance, we had informed the patient that their individual data will be kept confidential and will not be shared.

Locations